Clinical Trials on Vaginal Examination in Ireland

Total 54 results

Freya Biosciences ApS

Recruiting

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (Dyscover-3) (Dyscover-3)

Vaginal Flora Imbalance

Ireland
Freya Biosciences ApS

Completed

FB101 Intervention in Women Screened to Have Vaginal Dysbiosis (DYSCOVER-1)

Vaginal Flora Imbalance

Ireland
Women and Infants Hospital of Rhode Island
Millennium Pharmaceuticals, Inc.

Terminated

Study of Velcade and Irinotecan in Advanced Cervical, Vulvar, or Vaginal Cancer

Cervical Cancer

United States
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Advanced Vaginal Adenocarcinoma | Advanced Vaginal Adenosquamous Carcinoma | Advanced Vaginal Squamous Cell Carcinoma | Cervical Squamous Cell Carcinoma | Stage IB2 Cervical Cancer AJCC v6 and v7 | Stage II Cervical Cancer AJCC v7 | Stage... and other conditions

United States, Canada, Puerto Rico
University of Texas Southwestern Medical Center
Pfizer; University of Alabama at Birmingham; Women and Infants Hospital of Rhode...

Completed

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen (IMPROVE)

Pelvic Organ Prolapse | Pelvic Floor Disorders | Cystocele | Uterine Prolapse | Vaginal Vault Prolapse | Vaginal Prolapse | Urogenital Prolapse

United States
Brown University
Genentech, Inc.

Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

Follicular Lymphoma | B-cell Lymphoma | Marginal Zone Lymphoma

United States
The Cleveland Clinic
Foundation for Female Health Awareness

Completed

Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy (VeLVET)

Menopause | Atrophic Vaginitis

United States
Solace Therapeutics, Inc.

Terminated

Vesair Balloon Confirmatory Trial (VECTOR) (VECTOR)

Stress Urinary Incontinence

United States
University of Limerick

Completed

Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis

Multiple Sclerosis | Urinary Bladder, Overactive | Lower Urinary Tract Symptoms | Urinary Incontinence | Urinary Bladder, Neurogenic | Urinary Incontinence, Urge | Nocturia | Bladder Dysfunction | Neurogenic Bladder Dysfunction | Urinary Frequency More Than Once at Night

Ireland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Vaginal Atrophy

United States
Prasco LLC

Completed

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

Vulvar and Vaginal Atrophy

United States
University of Vermont

Suspended

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

Breast Neoplasms | Vaginitis | Dyspareunia

United States
Cork University Hospital
Fotona d.o.o.

Unknown

The Efficacy and Safety of Fotona Smooth® Device for the Treatment of Stress Urinary Incontinence

Stress Urinary Incontinence

United Kingdom, Switzerland, Germany, Greece, Ireland, Slovenia
Women and Infants Hospital of Rhode Island

Completed

Computerized-Adaptive Testing: Feasibility In Women With Pelvic Floor Disorders (CAT) (CAT)

Urinary Incontinence

United States
NRG Oncology
National Cancer Institute (NCI)

Completed

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Breast Carcinoma | Cervical Carcinoma | Vaginal Carcinoma | Ovarian Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Postmenopausal

United States
EndoCeutics Inc.

Completed

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Vaginal Atrophy

United States, Canada
The Miriam Hospital

Unknown

Fat Grafting Technique Using Autologous Adipose Tissue Lipogems in Patients Suffering From Stress Urinary Incontinence

Urinary Incontinence,Stress

United States
Precision Therapeutics

Terminated

ChemoFx® PRO - A Post-Market Data Collection Study

Cervical Cancer | Uterine Neoplasms | Ovarian Cancer | Fallopian Tube Cancer | Vulvar Cancer | Endometrial Cancer | Vaginal Cancer | Peritoneal Cancer

United States
Coloplast A/S

Completed

Virtue® European Study

Stress Urinary Incontinence

Belgium, Germany, Italy, France, Ireland, Spain, United Kingdom, Netherlands
Women and Infants Hospital of Rhode Island
University of Alabama at Birmingham; Hartford Hospital

Unknown

Cancer of the Uterus and Treatment of Stress Urinary Incontinence (CUTI)

Stress Urinary Incontinence | Endometrial Cancer

United States
National Institute of Diabetes and Digestive and...
University of California, San Francisco

Completed

Program to Reduce Incontinence by Diet and Exercise (PRIDE)

Urinary Incontinence

United States
BeiGene

Recruiting

A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY)

Marginal Zone Lymphoma | Relapsed/Refractory Follicular Lymphoma

United States, Italy, Spain, China, United Kingdom, Australia, Israel, Korea, Republic of, France, Brazil, Ireland, Czechia, Romania, Argentina, Puerto Rico, Austria
Solace Therapeutics, Inc.

Terminated

Vesair Clinical Trial (VAPOR)

Stress Urinary Incontinence

United States
Gnankang Sarah Napoe

Recruiting

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence (BUTTON)

Urinary Incontinence, Urge | Overactive Bladder Syndrome

United States
The Cleveland Clinic
Duke University; Medstar Health Research Institute; Women and Infants Hospital... and other collaborators

Completed

Study Comparing TVT With TVT-SECUR for the Treatment of Stress Urinary Incontinence (SECURiTy)

Stress Urinary Incontinence

United States
Incyte Corporation

Active, not recruiting

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. (InMIND)

Follicular Lymphoma | Marginal Zone Lymphoma

Finland, United States, Spain, Korea, Republic of, Canada, Israel, Turkey, United Kingdom, Netherlands, Greece, Italy, France, Taiwan, Germany, Belgium, Japan, Czechia, Switzerland, Ireland, Poland, Ukraine, Australia, Denmark, Hungary, Swede... and more
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Combined Treatment for Mixed Incontinence (ESTEEM)

Urinary Incontinence, Stress | Urinary Incontinence, Urge

United States
Brown University
The Miriam Hospital; Rhode Island Hospital; Spectrum Pharmaceuticals, Inc

Completed

Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma (BRiM)

Lymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Lymphoma, B-Cell, Marginal Zone | Waldenstrom Macroglobulinemia | Lymphoma, Small-Cell

United States
Women and Infants Hospital of Rhode Island
Patient-Centered Outcomes Research Institute; University of California, San... and other collaborators

Recruiting

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence (BEST)

Urgency Urinary Incontinence

United States
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Not yet recruiting

Training for Urinary Leakage Improvement After Pregnancy (TULIP)

Urinary Incontinence | Delivery Complication

United States
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Sling vs Botox for Mixed Incontinence (MUSA)

Urinary Incontinence, Stress | Urinary Incontinence, Urge

United States
Wake Forest University Health Sciences
Foundation for Female Health Awareness

Completed

Retropubic vs. Single-Incision Mid-Urethral Sling for Stress Urinary Incontinence

Stress Urinary Incontinence | Pelvic Floor Disorders

United States
University of California, San Francisco
Pfizer

Completed

Bringing Simple Urge Incontinence Diagnosis & Treatment to Providers (BRIDGES) (BRIDGES)

Overactive Bladder | Urge Urinary Incontinence

United States
Solace Therapeutics, Inc.

Completed

Solace Stress Urinary inContinence Control Efficacy and Safety Study (SUCCESS)

Stress Urinary Incontinence

United States
Genmab
AbbVie

Active, not recruiting

First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (EPCORE™ NHL-1)

Small Lymphocytic Lymphoma (SLL) | DLBCL | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | MCL | Marginal Zone Lymphoma (MZL) | High-grade B-cell Lymphoma (HGBCL) | FL

Korea, Republic of, United States, Australia, Singapore, Netherlands, Sweden, France, Finland, United Kingdom, Spain, Germany, Denmark, Italy, Poland, Canada
Sanofi

Completed

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Overactive Bladder

United States
Athena Feminine Technologies, Inc.

Completed

Athena Pelvic Muscle Trainer - DUETS Trial (DUETS)

Urinary Incontinence

United States, Virgin Islands (U.S.)
Urovant Sciences GmbH

Completed

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

Overactive Bladder With Urge Urinary Incontinence

United States
Schrödinger, Inc.

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

Follicular Lymphoma | Splenic Marginal Zone Lymphoma | Burkitt Lymphoma | Plasmablastic Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Lymphoplasmacytic Lymphoma | Non Hodgkin Lymphoma | Primary Effusion Lymphoma | DLBCL | High-grade B-cell Lymphoma | Primary Mediastinal... and other conditions

United States, Moldova, Republic of
Duramed Research

Completed

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

Urinary Incontinence

United States, Canada
Pfizer

Completed

An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Urinary Incontinence, Stress

United States, Canada
GTx

Completed

Study to Assess Enobosarm (GTx-024) in Postmenopausal Women With Stress Urinary Incontinence (ASTRID)

Stress Urinary Incontinence

United States
Allergan

Completed

BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary Incontinence (APOLLO)

Urinary Incontinence | Overactive Bladder With Urinary Incontinence

United States, Canada
Gynecologic Oncology Group
National Cancer Institute (NCI)

Completed

Collecting Tumor Samples From Patients With Gynecological Tumors

Melanoma | Malignant Mesothelioma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Gestational Trophoblastic Tumor | Cervical Adenocarcinoma and other conditions

United States
GlaxoSmithKline

Completed

A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder

Overactive Bladder | Incontinence, Urinary and Urinary Bladder, Overactive

United States, Canada
GTx

Withdrawn

Study to Assess Long-Term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
GTx

Withdrawn

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Stress Urinary Incontinence

United States
TG Therapeutics, Inc.

Terminated

Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma (UNITY-NHL)

Follicular Lymphoma | Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma

United States, Poland, Australia, Italy, United Kingdom, Israel, Korea, Republic of, Slovakia, Spain
Celldex Therapeutics
Merck Sharp & Dohme LLC

Completed

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Melanoma | Follicular Lymphoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Pancreatic Adenocarcinoma | Ovarian Cancer | Fallopian Tube Cancer | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Non-Hodgkin Lymphoma | ... and other conditions

United States
BeiGene

Recruiting

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Follicular Lymphoma | Waldenström Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | B-cell Malignancy

United States, Spain, Italy, Australia, France, Korea, Republic of, Canada, Georgia, Sweden, Germany, Moldova, Republic of

Clinical Trials on Vaginal Examination in Ireland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malawi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations